GE HealthCare Technologies (NASDAQ:GEHC) Upgraded to Hold at BMO Capital Markets

BMO Capital Markets upgraded shares of GE HealthCare Technologies (NASDAQ:GEHC) to a hold rating in a report released on Wednesday,Zacks.com reports.

GEHC has been the topic of several other research reports. BTIG Research dropped their target price on shares of GE HealthCare Technologies from $85.00 to $80.00 and set a “buy” rating on the stock in a research report on Wednesday, April 29th. Oppenheimer restated an “outperform” rating and set a $85.00 price target on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. The Goldman Sachs Group reaffirmed a “neutral” rating on shares of GE HealthCare Technologies in a research note on Monday, June 8th. Rothschild & Co Redburn lowered their price objective on GE HealthCare Technologies from $110.00 to $98.00 in a report on Thursday, April 30th. Finally, Wells Fargo & Company decreased their target price on GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating on the stock in a research report on Thursday, April 30th. Ten research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $79.71.

GE HealthCare Technologies Trading Up 0.0%

Shares of GEHC stock opened at $64.70 on Wednesday. GE HealthCare Technologies has a 1-year low of $58.75 and a 1-year high of $89.77. The company has a market cap of $29.43 billion, a price-to-earnings ratio of 15.48, a PEG ratio of 1.76 and a beta of 0.72. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. The stock has a 50 day simple moving average of $63.33 and a 200-day simple moving average of $72.71.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion during the quarter, compared to analyst estimates of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. GE HealthCare Technologies’s revenue was up 7.4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, equities research analysts expect that GE HealthCare Technologies will post 4.89 EPS for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, July 24th. GE HealthCare Technologies’s payout ratio is currently 3.35%.

Insider Buying and Selling at GE HealthCare Technologies

In other news, insider Frank R. Jimenez purchased 1,750 shares of the company’s stock in a transaction dated Thursday, April 30th. The stock was acquired at an average price of $60.45 per share, with a total value of $105,787.50. Following the purchase, the insider directly owned 93,932 shares in the company, valued at approximately $5,678,189.40. This represents a 1.90% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Rodney F. Hochman bought 1,618 shares of the business’s stock in a transaction on Tuesday, May 12th. The shares were acquired at an average cost of $62.03 per share, with a total value of $100,364.54. Following the purchase, the director owned 1,618 shares of the company’s stock, valued at $100,364.54. The trade was a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders have bought 21,847 shares of company stock worth $1,361,355. Corporate insiders own 0.36% of the company’s stock.

Institutional Trading of GE HealthCare Technologies

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Banque Cantonale Vaudoise boosted its holdings in GE HealthCare Technologies by 16,539.1% during the 1st quarter. Banque Cantonale Vaudoise now owns 25,957 shares of the company’s stock valued at $1,849,000 after acquiring an additional 25,801 shares during the period. Allstate Corp increased its stake in GE HealthCare Technologies by 100.3% during the fourth quarter. Allstate Corp now owns 32,688 shares of the company’s stock worth $2,681,000 after purchasing an additional 16,365 shares during the period. Temasek Holdings Private Ltd acquired a new stake in shares of GE HealthCare Technologies during the third quarter worth about $99,922,000. Salem Investment Counselors Inc. boosted its stake in shares of GE HealthCare Technologies by 9.2% in the fourth quarter. Salem Investment Counselors Inc. now owns 176,452 shares of the company’s stock valued at $14,473,000 after purchasing an additional 14,867 shares during the period. Finally, Nordea Investment Management AB boosted its stake in shares of GE HealthCare Technologies by 564.4% in the fourth quarter. Nordea Investment Management AB now owns 284,344 shares of the company’s stock valued at $23,515,000 after purchasing an additional 241,548 shares during the period. Hedge funds and other institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.